<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03917927</url>
  </required_header>
  <id_info>
    <org_study_id>1601</org_study_id>
    <nct_id>NCT03917927</nct_id>
  </id_info>
  <brief_title>A Clinical Study of the Eztetic Dental Implant System</brief_title>
  <acronym>RoseQuartz</acronym>
  <official_title>A Prospective Multicenter Study of the Integration Success of the Eztetic Dental Implant System in Immediate Loading Cases</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Zimmer Biomet</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Zimmer Biomet</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This will be a prospective, observational multicenter study. All implants will be placed in&#xD;
      the anterior maxilla or mandible and immediately loaded with a provisional prosthesis out of&#xD;
      occlusion. Final restorations insertion will take place no later than 6 months following&#xD;
      implant placement surgery. All implants will be restored with a single crown or splinted to a&#xD;
      pre-existing implant if in the pre-molar region (no 2 adjacent edentulous sites).&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This will be a prospective, observational study in which patients in need of dental implants&#xD;
      in the anterior regions of the maxilla or mandible will be treated with the Eztetic dental&#xD;
      implant(s). Qualified patients will be those with one or more edentulous area in the anterior&#xD;
      maxilla or mandible needing a single (restored as a single crown; if in the pre-molar region,&#xD;
      it is recommended implant be splinted to another tooth or implant; no 2 adjacent edentulous&#xD;
      sites). Qualified patients should have presence of posterior teeth or a stable posterior&#xD;
      occlusion. All implants will be placed in a single-stage manner. A provisional abutment will&#xD;
      be placed and a temporary crown will be placed (cemented or screw-retained) out of occlusion&#xD;
      at implant placement surgery visit. Impressions for permanent prosthesis fabrication will&#xD;
      take place at 6 weeks and prosthesis placement will take place at 2 months. Final prosthesis&#xD;
      insertion will take place no later than 6 months following implant placement surgery.&#xD;
      Resonance frequency assessment procedures will be done at implant placement surgery and at&#xD;
      prosthesis insertion. Implant survival will be the primary study endpoint. Crestal bone&#xD;
      regression will be the secondary study endpoint. Enrollment will continue until 20 patients&#xD;
      have completed final prosthetic treatment at study center.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">January 8, 2019</start_date>
  <completion_date type="Anticipated">May 2023</completion_date>
  <primary_completion_date type="Anticipated">May 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Implant survival</measure>
    <time_frame>2 years</time_frame>
    <description>survival (no declaration of failure) of dental implant</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Marginal bone changes</measure>
    <time_frame>2 years</time_frame>
    <description>Change in bone levels around dental implant</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Edentulous Jaw</condition>
  <arm_group>
    <arm_group_label>Eztetic dental implant</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Eztetic 3.1mm diameter, lengths 8, 10, 11.5, 13, 16 mm</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Eztetic dental implant</intervention_name>
    <description>narrow diameter dental implant</description>
    <arm_group_label>Eztetic dental implant</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Patients of either sex and at least 18 years of age&#xD;
&#xD;
          2. Patients for whom a decision has already been made to use a dental implant for the&#xD;
             restoration of existing partial edentulism in the anterior (central and lateral&#xD;
             incisors), canine or pre-molar regions in the mandible or maxilla. Placing implant in&#xD;
             canine region should be in a healed site (not for immediate extraction)&#xD;
&#xD;
          3. Immediate extraction or a prior extracted site&#xD;
&#xD;
          4. Intact buccal table as verified by Cone Beam Computed Tomography (CBCT) or radiography&#xD;
             during surgery. If absent, patient should be excluded from enrollment in the study.&#xD;
&#xD;
          5. Patients must be physically able to tolerate conventional surgical and restorative&#xD;
             procedures.&#xD;
&#xD;
          6. Patients with a facial lingual width of at least 5.1mm and inner tooth width of at&#xD;
             least 6mm.&#xD;
&#xD;
          7. Patients having a thick gingival biotype (based on the lack of transparency of the&#xD;
             periodontal probe through the gingival margin while probing the buccal sulcus) will be&#xD;
             preferred but lack of this characteristic will not disqualify a patient from inclusion&#xD;
             in this study.&#xD;
&#xD;
          8. Presence of opposing dentition with a functional occlusion that permits the&#xD;
             restoration with a non-occluding provisional prosthesis.&#xD;
&#xD;
          9. Patients who provide a signed informed consent; a patient having implant placement&#xD;
             surgery will continue participation in the study regardless of whether or not they&#xD;
             receive restorative treatment according to protocol (protocol deviation)&#xD;
&#xD;
         10. Patients who agree to be evaluated for each study visit.&#xD;
&#xD;
         11. Minimum primary stability, insertion torque &gt; 35Ncm (this will be a criteria that is&#xD;
             met at the time of surgery)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Patients with known systemic diseases such as uncontrolled diabetes, endocrine&#xD;
             disease, heart disease, immuno-compromised, or mental disorders.&#xD;
&#xD;
          2. Patients with current use of non-steroidal anti-inflammatory drugs, bisphosphonates or&#xD;
             corticosteroid treatments.&#xD;
&#xD;
          3. Patients with active infection or severe inflammation in the areas intended for&#xD;
             implant placement.&#xD;
&#xD;
          4. Prisoners&#xD;
&#xD;
          5. Patients with a &gt; 10 cigarette per day smoking habit.&#xD;
&#xD;
          6. Patients with a history of therapeutic radiation to the head or jaw.&#xD;
&#xD;
          7. Patients in need of bone grafting at the site of the intended implantation site(s).&#xD;
&#xD;
          8. Patients who are known to be pregnant at the screening visit or planning to become&#xD;
             pregnant within 6 months of study enrollment.&#xD;
&#xD;
          9. Patients with evidence of severe parafunctional habits such as bruxing or clenching.&#xD;
&#xD;
         10. Patients with HIV or Hepatitis infection&#xD;
&#xD;
         11. Patients who have previously failed implants at the site intended for study implant&#xD;
             placement&#xD;
&#xD;
         12. Patients in need of other treatments or surgeries at a site adjacent to the intended&#xD;
             implantation site&#xD;
&#xD;
         13. Patients with a history of severe periodontal disease&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Burak Yilmaz, DDS</last_name>
    <role>Principal Investigator</role>
    <affiliation>Ohio State University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Ohio State University</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <zip>43210</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Virginia Commonwealth University</name>
      <address>
        <city>Richmond</city>
        <state>Virginia</state>
        <zip>23298-0566</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>San Jose Hospital</name>
      <address>
        <city>Santiago</city>
        <country>Chile</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Dr. Tasso-Eyke von Haussen</name>
      <address>
        <city>Mainz</city>
        <zip>55128</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Chile</country>
    <country>Germany</country>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>April 13, 2019</study_first_submitted>
  <study_first_submitted_qc>April 13, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">April 17, 2019</study_first_posted>
  <last_update_submitted>April 23, 2021</last_update_submitted>
  <last_update_submitted_qc>April 23, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 26, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Jaw, Edentulous</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

